logo

Mersana Therapeutics Inc (MRSN) Stock: A Year of Highs and Lows in the Market

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Mersana Therapeutics Inc’s current trading price is -47.97% away from its 52-week high, while its distance from the 52-week low is 524.53%. The stock’s price range for this period has been between $0.80 and $9.62 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.92 million for the day, a number notably higher than the average daily volume of 2.13 million over the last three months.

Mersana Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $9.62 on 06/12/23, while the lowest price for the same period was registered at $0.80 on 07/27/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Mersana Therapeutics Inc (MRSN) has experienced a quarterly rise of 147.77% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 607.11M and boasts a workforce of 123 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.77, with a change in price of +3.61. Similarly, Mersana Therapeutics Inc recorded 2,155,886 in trading volume during the last 100 days, posting a change of +257.50%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MRSN stands at 0.92. Similarly, the long-term debt-to-equity ratio is also 0.77.

MRSN Stock Stochastic Average

Mersana Therapeutics Inc’s raw stochastic average for the past 50 days is presently 69.42%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 53.47%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 70.13% and 76.18%, respectively.

MRSN Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 115.73% this year. Over the last six months, there has been a weaker performance of 250.00%. The price of MRSN fallen by 30.68% during the last 30 days period. For the last 5-days stocks have slided -14.44%.